Skip to main content
. Author manuscript; available in PMC: 2016 Dec 19.
Published in final edited form as: Lancet. 2015 Sep 28;386(10012):2507–2519. doi: 10.1016/S0140-6736(15)00310-4

Figure 3. Incidence of malaria infection, clinical malaria, and all-cause sick-clinic visits during pregnancy by treatment group in the intention-to-treat population.

Figure 3

Data are the number of women with an event and the number of events/person-time of follow-up, with incidence rate per 100 person-years, unless otherwise specified. Malaria infection defined by microscopy or PCR. IRR=incidence rate ratio. ISTp-DP=intermittent screening and treatment during pregnancy with dihydroartemisinin–piperaquine. IPTp-DP=intermittent preventive treatment during pregnancy with dihydroartemisinin–piperaquine. IPTp-SP=intermittent preventive treatment during pregnancy with sulfadoxine–pyrimethamine.